Groowe
/
Newsroom
/ ZBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZBIO
News
Zenas BioPharma, Inc. Common Stock
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis
globenewswire.com
Oct 8, 2025 2:00 AM
ZBIO
← Newer
Page 16 of 16
Older →